Neuralink, the brain-computer interface company founded by Elon Musk, is preparing to enter what Musk calls “high-volume production” of brain implants by 2026. According to Musk, the company also plans to shift to fully automated surgical procedures, dramatically accelerating the scale at which these devices can be implanted in humans. Neuralink’s stated goal is medical—helping patients with spinal cord injuries and paralysis regain functional abilities. Early trials have already enabled recipients to browse the internet, post on social media, and control digital tools using only their thoughts.

The company began human trials in 2024 after overcoming initial safety objections from the FDA and now reports that 12 people worldwide are living with the implant. With $650 million in new funding and ambitions for automation, Neuralink represents a major leap toward direct human-machine integration. For prophecy-minded observers, this development raises deeper questions about the trajectory of technology and the human body. What begins as therapy can quickly become enhancement, normalization, and dependency. As brain-machine interfaces move from experimental to industrial scale, the line between healing and transformation grows thinner—underscoring the need for discernment in an age racing toward transhuman realities.

SOURCE: Reuters via MSN